Detailed Information
Cited 0 time in 
Cited 19 time in 
Cited 19 time in
Metadata Downloads
Recent advances in idiopathic pulmonary fibrosis
- Issue Date
- 2013
- Keywords
- Clinical trial; Etiology; Idiopathic pulmonary fibrosis
- Citation
- Tuberculosis and Respiratory Diseases, v.74, no.1, pp 1 - 6
- Pages
- 6
- Indexed
- SCOPUS
KCI
- Journal Title
- Tuberculosis and Respiratory Diseases
- Volume
- 74
- Number
- 1
- Start Page
- 1
- End Page
- 6
- ISSN
- 1738-3536
2005-6184
- Abstract
- The concept on idiopathic pulmonary fibrosis (IPF) pathogenesis has progressed from chronic inflammation to aberrant wounding healing and even more to the current paradigms of a multifactorial and heterogeneous disease process. Despite the growth of clinical trials for IPF, most of the results, including N-acetylcysteine combination, warfarin, and bosentan, were disappointing. On the other hand, there have been a number of important developments; the foremost is the licensing of pirfenidone in Europe and Asia. In this article, we briefly review the recent knowledge of pathogenesis of IPF. We also summarize the recent clinical trials regarding the management of IPF. Copyright©2013. The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved.
- Files in This Item
- There are no files associated with this item.
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Lee, Eun Joo
- Anam Hospital (Department of Pulmonary, Allergy, and Critical Care Medicine, Anam Hospital)